Abstract
Background: We described lifestyle changes one year after acute coronary syndrome (ACS) among patients in Arabian Gulf countries.
Methodology: Data of patients admitted to 29 hospitals in 4 countries with the diagnosis of ACS were analysed from Gulf citizens with ACS events (Gulf COAST) registry. A total of 3565 ACS patients recruited in the Gulf COAST registry had a one-year follow up available. There was a significant correlation between return to work and the age of patient (p < .001). At one-year post ACS, the majority were performing their usual activities (93%), but only 39% were exercising. Smoking cessation was successful in 60% of patients and most non-quitters tried or considered quitting (18 and 21% of the total population of smokers, respectively). Sexual activity was reported from 2290 male patients at one-year follow up. The majority reported performing sexual activity (66%) with no fear of sexual intercourse (57%).
Results and Conclusion: At one year after an ACS, the majority of our patients returned to their work, sexual activity and other usual activity. Clearly, improvement is needed when it comes to smoking cessation and exercise.
Keywords: Lifestyle, acute coronary syndrome, arabian gulf, middle east, registries, CRF.
Graphical Abstract
Current Vascular Pharmacology
Title:Lifestyle Changes among ACS Survivors in Arabian Gulf Countries (Gulf COAST Registry)
Volume: 16 Issue: 4
Author(s): F. Al-Roomi*, A. Khesroh, I. Al-Zakwani, S. Attur, W. Rashed and M. Zubaid
Affiliation:
- Department of Internal Medicine, Al-Amiri Hospital, Kuwait City,Kuwait
Keywords: Lifestyle, acute coronary syndrome, arabian gulf, middle east, registries, CRF.
Abstract: Background: We described lifestyle changes one year after acute coronary syndrome (ACS) among patients in Arabian Gulf countries.
Methodology: Data of patients admitted to 29 hospitals in 4 countries with the diagnosis of ACS were analysed from Gulf citizens with ACS events (Gulf COAST) registry. A total of 3565 ACS patients recruited in the Gulf COAST registry had a one-year follow up available. There was a significant correlation between return to work and the age of patient (p < .001). At one-year post ACS, the majority were performing their usual activities (93%), but only 39% were exercising. Smoking cessation was successful in 60% of patients and most non-quitters tried or considered quitting (18 and 21% of the total population of smokers, respectively). Sexual activity was reported from 2290 male patients at one-year follow up. The majority reported performing sexual activity (66%) with no fear of sexual intercourse (57%).
Results and Conclusion: At one year after an ACS, the majority of our patients returned to their work, sexual activity and other usual activity. Clearly, improvement is needed when it comes to smoking cessation and exercise.
Export Options
About this article
Cite this article as:
Al-Roomi F.*, Khesroh A., Al-Zakwani I., Attur S., Rashed W. and Zubaid M., Lifestyle Changes among ACS Survivors in Arabian Gulf Countries (Gulf COAST Registry), Current Vascular Pharmacology 2018; 16 (4) . https://dx.doi.org/10.2174/1570161115666170529090700
DOI https://dx.doi.org/10.2174/1570161115666170529090700 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anthracyclines Still Prove Effective in Anticancer Therapy
Mini-Reviews in Medicinal Chemistry An Update on the Cardiovascular Effects of Quercetin, a Plant Flavonoid
Current Nutrition & Food Science Novel Anti-Arrhythmic Drugs for Atrial Fibrillation Management
Current Vascular Pharmacology Meet Our Editor
Central Nervous System Agents in Medicinal Chemistry Molecular and Cellular Mechanisms in the Pathophysiology of Severe Head Injury
Current Pharmaceutical Design Blockade of Ser16-Hsp20 Phosphorylation Attenuates Neuroprotection Dependent Upon Bcl-2 and Bax
Current Neurovascular Research Recent Advance in Non-invasive Continuous Blood Pressure Measurement System
Recent Patents on Biomedical Engineering (Discontinued) The Therapeutic Potential of Angiotensin-(1-7) as a Novel Renin- Angiotensin System Mediator
Mini-Reviews in Medicinal Chemistry Stem Cells: In Sickness and in Health
Current Stem Cell Research & Therapy A Molecular Link Between Diabetes and Breast Cancer: Therapeutic Potential of Repurposing Incretin-based Therapies for Breast Cancer
Current Cancer Drug Targets Lymphatics and Inflammation
Current Medicinal Chemistry Blood-based Amyloid and Tau Biomarker Tests For Alzheimer’s Disease
Neuroscience and Biomedical Engineering (Discontinued) Discovery of a Novel Anti-Cancer Agent Targeting Both Topoisomerase I & II as Well as Telomerase Activities in Human Lung Adenocarcinoma A549 Cells In Vitro and In Vivo: Cinnamomum verum Component Cuminaldehyde
Current Cancer Drug Targets Risk Models and Scores of Cardiovascular Disease in Patients with Diabetes Mellitus
Current Pharmaceutical Design Comprehensive Profiling of Protein Ubiquitination for Drug Discovery
Current Pharmaceutical Design Limitations and Potential Clinical Application on Contrast Echocardiography
Current Cardiology Reviews Poloxamer 188 (P188) as a Membrane Resealing Reagent in Biomedical Applications
Recent Patents on Biotechnology Anti-inflammatory Property of AMP-activated Protein Kinase
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Hydroxychloroquine and Azithromycin Combination in the Management of COVID-19 Infection: Safety and Effectiveness Challenges
Current Drug Safety Endothelin Receptor Antagonists: A New Therapeutic Option for Improving the Outcome after Solid Organ Transplantation?
Current Vascular Pharmacology